Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastien Vergez

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2020
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric studyDorian Culié, Quentin Lisan, Charlotte Leroy, et al.
Journal of Voice : Official Journal of the Voice Foundation|July 1, 2020
Features of Mild-to-Moderate COVID-19 Patients With DysphoniaJerome R Lechien, Carlos M Chiesa-Estomba, Pierre Cabaraux, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2020
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric studyDorian Culié, Quentin Lisan, Charlotte Leroy, et al.
Journal of Voice : Official Journal of the Voice Foundation|July 1, 2020
Features of Mild-to-Moderate COVID-19 Patients With DysphoniaJerome R Lechien, Carlos M Chiesa-Estomba, Pierre Cabaraux, et al.
Pageof 4